Cargando…
Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease
BACKGROUND: Huntington's Disease (HD) is an inherited autosomal dominant genetic disorder in which neuronal tissue degenerates. The pathogenesis of the disease appears to center on the development of protein aggregates that arise initially from the misfolding of the mutant HD protein. Mutant hu...
Autores principales: | Skogen, Michael, Roth, Jennifer, Yerkes, Sarah, Parekh-Olmedo, Hetal, Kmiec, Eric |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609172/ https://www.ncbi.nlm.nih.gov/pubmed/17014717 http://dx.doi.org/10.1186/1471-2202-7-65 |
Ejemplares similares
-
Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx(5cv )mice
por: Maguire, Katie, et al.
Publicado: (2009) -
Stacking of G-quadruplexes: NMR structure of a G-rich oligonucleotide with potential anti-HIV and anticancer activity(†)
por: Do, Ngoc Quang, et al.
Publicado: (2011) -
Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease
por: Stoker, Thomas B., et al.
Publicado: (2020) -
Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
por: Rook, Morgan E., et al.
Publicado: (2022) -
Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides
por: Schwartz, Timothy R, et al.
Publicado: (2007)